1. Jones, R. N., Barry, A. L., Thornsberry, C., Gerlach, E. H., Fuchs, P. C., Gavan, Th. L., Sommers, H. M. Ceftazidime, a pseudomonas-active cephalosporin:in vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests. J. Antimicrob. Chemother. 8 (1981) 187–211.
2. Fuchs, P. C., Barry, A. L., Thornsberry, C., Jones, R. N., Gavan, Th. L., Gerlach, E. H., Sommers, H. M. Cefotaxime:In vitro activity and tentative interpretive standards for disk susceptibility testing. Antimicrob. Agents Chemother. 18 (1980) 88–93.
3. O'Donnell, E., Raeder, R., Gilardi, G., Freimer, E. H.: Antibacterial activity of MK 0787 and moxalactam againstPseudomonas sp. and other nonfermenters. Abstracts, Annual Meeting of the American Society for Microbiology, Washington, D.C. 1981, p. 9.
4. Kesado, T., Hashizume, T., Asahi, Y. Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics. Antimicrob. Agents Chemother. 17 (1980) 912–917.
5. Schassan, H.-H., Hörning, R., Malottke, R.: Activity of thienamycin in comparison with cefotaxime and other beta-lactams against clinically important gram-negative nonfermenters andEnterobacteriaceae. Abstracts, 12th International Congress of Chemotherapy, Florence 1981, p. 112.